Evidence map›Paper›PMID 42500224›Full record

ArticleACS physical chemistry Au2026

Understanding Molecular Excited States at the Metal-Molecule Interface via Transition Density Matrix AnalysisA Case Study of Azobenzene Thiols on Gold.

Nicolas Jahn, Evgenii Titov

Abstract read
In one paragraph

Article in ACS physical chemistry Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nicolas JahnInstitute of Chemistry, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Potsdam-Golm, Germany.ORCID https://orcid.org/0009-0000-7578-5154
Evgenii TitovInstitute of Chemistry, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Potsdam-Golm, Germany.ORCID https://orcid.org/0000-0002-1732-1826

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Noble metal nanoparticles are rapidly gaining popularity as novel catalytic platforms to influence chemical reactions in various ways. Despite an increasingly large number of studies, many key processes especially at the metal-molecule interface are fundamentally still not fully understood up to this day. Throughout this work, we present a systematic study targeting the molecular excited states of covalently linked azobenzenes (ABs) on gold via a combination of time-dependent density functional theory and tight-binding calculations with transition density matrix analysis. We find that the optically bright ππ* state is strongly resonant to close-lying local gold excitations, which leads to splitting and redshift of the ππ* state and increased UV/vis absorption around the ππ* excitation energy. We show that these findings hold true across different AB isomers and demonstrate how a systematic variation of the AB-gold distance leads to a gradual localization of the ππ* excitation. Moreover, we discuss how a direct electronic interaction between the AB and the gold surface leads to the formation of delocalized hybrid states and investigate the exciton formation of AB dimers at the metal interface. Our results are carefully verified across a wide range of computational parameters including a large number of different density functionals, basis sets, and gold clusters of varying forms and sizes. The presented workflow is easily applicable to other functional molecules on metal surfaces to further broaden the understanding of substrate-surface interactions at the interface.

Indexed as

azobenzeneDFTDFTBexcited stategoldtransition density matrix

Identifiers

PMID42500224
PMCPMC13397451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.